In a world-first, Chinese researchers have successfully transplanted a genetically engineered pig liver into a living human, ...
October marks Liver Cancer Awareness Month, an initiative that brings attention to the disease identified by NIH as the third ...
A site development and transportation contractor says two subs’ work had numerous deficiencies, and claims a total of $18.3 ...
Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...
A groundbreaking medical milestone was achieved with the first successful transplantation of a genetically engineered pig ...
Hyponatremia, or low blood sodium, can lead to dangerous fluid imbalances and cell swelling, potentially causing seizures or ...
Data from the Phase Ib Beamion LUNG-1 trial evaluating HERNEXEOS® (zongertinib tablets) in treatment-naïve patients with advanced HER2 (ERBB2)-mutant ...
BRIUMVI is currently approved in the United States, as well as several countries outside of the U.S., as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in ...
Mr Andrews contacted the medical team at Massachusetts General Hospital ( MGH) that had carried out the operation. On January ...
BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...
Study in healthy adults: two common processed fats delivered similar cholesterol, inflammation, and vessel-function results ...
TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback